Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids

被引：0

作者：

Talaulikar, Vikram Sinai ^{[1
]}

Manyonda, Isaac ^{[1
]}

机构：

[1] St Georges Hosp & Univ London, London SW17 0RE, England

来源：

WOMENS HEALTH | 2014年 / 10卷 / 06期

关键词：

fibroids; medical; myoma; SPRM; ulipristal acetate;

D O I：

10.2217/WHE.14.60

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Although it has been known for a long time that uterine fibroids respond to changes in sex steroid concentrations, it is the availability of selective progesterone receptor modulators such as ulipristal acetete that has provided the gynecologist with a novel option for medical management of uterine fibroids. Ulipristal acetate is presently licensed in Europe for use in women with symptomatic fibroids up to 3 months prior to surgery and has demonstrated good clinical efficacy and safety for this indication. Future trials will define the long-term safety of this drug and its role in medical management of uterine fibroids.

引用

页码：565 / 570

页数：6

共 50 条

[31] Series of 55 pregnancies following ulipristal acetate treatment of symptomatic uterine fibroids
Costa, Ana R.
Carvalho, Ana P.
Martins, Diana R.
Carvalho, Maria J.
Silva, Pedro T.
Roque, Silvia C.
Silva, Daniel P.
JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2020, 12 (3-4) : 170 - 175
[32] A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids
Ghonim, Mohamed
Magdy, Rana
Sabbour, Mohamed
Ghonim, Mohanad
Nabhan, Ashraf
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (02) : 141 - 148
[33] Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids
Tuschy, Benjamin
Gabbert, Mirja
Weiss, Christel
Hornemann, Amadeus
Wuhrer, Anne
Suetterlin, Marc
Berlit, Sebastian
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 228 : 106 - 110
[34] Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
Pourcelot, A. -G.
Capmas, P.
Fernandez, H.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2017, 46 (03) : 249 - 254
[35] Management of symptomatic uterine fibroids with ulipristal acetate: A retrospective, multicentric and nationwide study
Aguas, Fernanda
Guerreiro, Fernando
Ponte, Carlos
Gomes, Carolina
Martinho, Margarida
Vilhena, Vera
Silva, Daniel
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2020, 49 (08)
[36] Adverse symptoms during short-term use of ulipristal acetate in women with uterine myomas and/or adenomyosis
Hong, Yeon Hee
Han, Soo Jin
Lee, Dayong
Kim, Seul Ki
Jee, Byung Chul
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (04) : 865 - 870
[37] Pretreatment of Uterine Fibroids Using a Selective Progesterone Receptor Modulator - Ulipristal Acetate
Thompson, M.
Wong, M.
Opemuyi, I.
Madipola, N.
Ramadan, T.
Nnochiri, A.
Guttman, J.
20TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2015, : 205 - 210
[38] Uterine Bleeding Control with Ulipristal Acetate
Esteves, T.
Codorniz, A.
Matias, I.
Mineiro, S.
Caseiro, L.
Pereira, E.
Regalo, A.
Fernandes, F.
Ramos, A.
Carvalho, J.
20TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2015, : 71 - 76
[39] Effects of long-term intermittent pharmacological therapy with ulipristal acetate on reducing the volume of uterine fibroids and relieving symptoms
Kyeong, Hee-Kang
Choi, Jisu
Na, Yong-Jin
Kim, Hwi-Gon
MINERVA OBSTETRICS AND GYNECOLOGY, 2023, 75 (03) : 236 - 242
[40] Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis
Zakiyah, N.
van Asselt, A. D. I.
Postma, M. J.
JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (03) : 280 - 287

← 1 2 3 4 5 →